S. pombe strains used in this study are listed in
To construct the pom1-pom2K strain for the domain complementation experiments, the Pom1 kinase domain (amino acids 699–995) was replaced by KS-ura4 using PCR-based gene targeting to obtain strain pom1-ΔK::ura4+[90] (link). DNA (pom2K) encoding the Pom2 kinase domain (amino acids 518–814) was amplified and cloned into the TOPO vector. PCR fidelity was confirmed by sequencing. Then the ura4+ in pom1-ΔK::ura4+ was replaced by the pom2K fragment with 66 bp-long homologous sequences to the flanking regions of pom1 kinase domain. Positive clones were selected on 5-FOA plates and confirmed by PCR. The fusion gene was further confirmed by sequencing.
Cells were re-streaked from −80°C stock, grown 2–3 days on plates, and then inoculated into 5–15 ml YE5S liquid culture as described [91] (link). Cultures were kept in exponential phase for 36–48 h before microscopy except where specified. Strains with 3nmt1 or 41nmt1 promoter were grown in YE5S medium for at least 24 h, washed 3× with EMM5S, and then induced in EMM5S medium for 12–48 h before microscopy except where noted. Stock solutions of thiabendazole (TBZ; Sigma-Aldrich) and methyl benzimidazole-2-yl carbamate (MBC; Sigma-Aldrich) were made in DMSO at concentrations of 50 mg/ml and 5 mg/ml, respectively. The final working concentrations were 50 µg/ml for TBZ and 25 µg/ml for MBC. Cells were stained with Calcofluor and Hoechst 33342 (bisBenzimide) as described [92] (link). Stock solution of Hoechst 33342 (Sigma-Aldrich) was made in ddH2O at 1 mg/ml and kept in the dark at 4°C.